GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » Short-Term Capital Lease Obligation

Torii Pharmaceutical Co (TSE:4551) Short-Term Capital Lease Obligation : 円0 Mil (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co Short-Term Capital Lease Obligation?

Torii Pharmaceutical Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was 円0 Mil.

Torii Pharmaceutical Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (円0 Mil) to Dec. 2023 (円222 Mil) but then declined from Dec. 2023 (円222 Mil) to Mar. 2024 (円0 Mil).

Torii Pharmaceutical Co's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (円211 Mil) to Dec. 2022 (円283 Mil) but then declined from Dec. 2022 (円283 Mil) to Dec. 2023 (円222 Mil).


Torii Pharmaceutical Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Torii Pharmaceutical Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torii Pharmaceutical Co Short-Term Capital Lease Obligation Chart

Torii Pharmaceutical Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.00 85.00 211.00 283.00 222.00

Torii Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 222.00 -

Torii Pharmaceutical Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Torii Pharmaceutical Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Torii Pharmaceutical Co (TSE:4551) Business Description

Traded in Other Exchanges
N/A
Address
Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines